期刊
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
卷 18, 期 8, 页码 1884-1892出版社
WILEY
DOI: 10.1111/jth.14861
关键词
coagulation factor V; glycosylation; HILIC; mass spectrometer
资金
- National Heart, Lung, and Blood Institute [U54HL142019]
Background/Objective Coagulation factor V (FV), a multidomain glycoprotein, is an essential cofactor in the blood clotting cascade. FV deficiency is a rare bleeding disorder that results in poor clotting after an injury or surgery. The only treatment for the disease is infusions of fresh frozen plasma and blood platelets. Glycosylation affects the biological activity, pharmacokinetics, immunogenicity, and in vivo clearance rate of proteins in the plasma. The glycan profile of FV, as well as how it affects the activity, stability, and immunogenicity, remains unknown. Methods In this study, we comprehensively mapped the glycosylation patterns of human plasma-derived FV by combining multienzyme digestion, hydrophilic interaction chromatography enrichment of glycopeptides, and alternated fragmentation mass spectrometry analysis. Results/Conclusion A total of 57 uniqueN-glycopeptides and 51O-glycopeptides were identified, which were categorized into 40N-glycan and 17O-glycan compositions. Such glycosylation details are fundamental for future functional studies and therapeutics development. In addition, the established methodology can be readily applied to analyze glycosylation patterns of proteins with more than 2000 amino acids.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据